Teerlink, J. R., Felker, G. M., McMurray, J., Solomon, S., Cleland, J., Goldsmith, S., … Honarpour, N. (2019). EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF. In Journal of the American College of Cardiology (Vol. 73, pp. 691–691). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)31299-9

Teerlink, John R., G Michael Felker, John McMurray, Scott Solomon, John Cleland, Steven Goldsmith, Christopher Kurtz, et al. “EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF.” In Journal of the American College of Cardiology, 73:691–691. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31299-9.

Teerlink JR, Felker GM, McMurray J, Solomon S, Cleland J, Goldsmith S, et al. EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 691–691.

Teerlink, John R., et al. “EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 691–691. Crossref, doi:10.1016/s0735-1097(19)31299-9.

Teerlink JR, Felker GM, McMurray J, Solomon S, Cleland J, Goldsmith S, Kurtz C, Buchele G, Legg J, Malik F, Honarpour N. EFFECT OF OMECAMTIV MECARBIL IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION: RESULTS FROM COSMIC-HF. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 691–691.